Idaho Must Allow Gender Changes on Birth Certificates, Judge Rules
(BOISE, Idaho) — A federal judge says Idaho can’t bar transgender people from changing the sex listed on their birth certificates.In a ruling issued Monday, U.S. Magistrate Judge Candy Dale said the rules by the Idaho Department of Health and Welfare violated the Equal Protection Clause of the U.S. Constitution, served no rational government purpose and put transgender people at risk by forcing them to disclose their status when they present identification documents. “A rule providing an avenue to obtain a birth certificate with a listed sex that aligns with an individual’s gender identity promotes the health, well-being, and safety of transgender people without impacting the rights of others,” Dale wrote. Dale gave Idaho until April 6 to begin considering applications to change the sex listed on birth certificates under new, constitutionally sound rules. The ruling also says reissued birth certificates can’t include a record of the gender having been changed. Most states already allow such changes. But Idaho was one of four — including Kansas, Ohio and Tennessee — that prohibited transgender people from changing their birth certificates to reflect their gender identity. The ruling was a response to a lawsuit brought by two transgender women last year who said they faced hostility and harassment at places like grocery stores and government offices because they had to present identification that did not reflect their gender iden...
CONCLUSION: In our study, the Holladay 2 formula does not seem to be better than the others for calculating IOL power in non-standard eyes. Preoperative eye features in such non-standard cases should be taken into account before the surgery to choose the more suitable formula. PMID: 29685742 [PubMed - as supplied by publisher]
Authors: Belkhadir K, Benchekroun S, Regragui A, Cherkaoui O PMID: 29685741 [PubMed - as supplied by publisher]
CONCLUSION: Intraoperative digital marker system is associated with better TIOL alignment accuracy and better reproducibility than the manual ink-marking method. PMID: 29685740 [PubMed - as supplied by publisher]
Authors: Drissi Touzani K, Marrakchi M, Chraibi F, Abdellaoui M, Benatiya Andaloussi I, Tahiri H PMID: 29685739 [PubMed - as supplied by publisher]
CONCLUSION: IOIS is a diagnosis of exclusion, based on history, clinical course, response to steroid therapy, laboratory tests, or even biopsy in selected cases. Orbital imaging provides valuable clues for diagnosis of IOIS and for identification of affected structures. Prolonged steroid therapy is necessary as IOIS classically responds to steroids; nevertheless, partial recovery or relapses often occur. PMID: 29685738 [PubMed - as supplied by publisher]
CONCLUSION: This is the first study comparing the low- versus medium-power toric IOLs, the most widely used. This study suggests very good refractive results both with low- and medium-power toric IOLs with a single surgical procedure. PMID: 29685737 [PubMed - as supplied by publisher]
Authors: Yakymenko O, Schoultz I, Gullberg E, Ström M, Almer S, Wallon C, Wang A, Keita ÅV, Campbell BJ, McKay DM, Söderholm JD Abstract OBJECTIVE: Infliximab is important in the therapeutic arsenal of Crohn's disease (CD). However, its effect on mucosal barrier function is not fully understood. Adherent-invasive Escherichia coli (AIEC) are important in CD pathophysiology, but the transmucosal uptake routes are partly unknown. We investigated effects of infliximab on uptake of colon-specific AIEC HM427 across CD colonic mucosa. MATERIALS AND METHODS: Endoscopic biopsies from non-inflamed colon o...
CONCLUSIONS: This is the first study describing an association between VTE and IBS. The results suggest that specialist treated IBS patients have increased risk of VTE. PMID: 29688100 [PubMed - as supplied by publisher]
Authors: Fiorini G, Zullo A, Saracino IM, Pavoni M, Vaira D Abstract PURPOSE: Bacterial resistance toward the most used antibiotics is increasing in Helicobacter pylori strains worldwide. Emergence of multidrug resistance significantly affects the efficacy of standard therapy regimens. Therefore, monitoring for primary antimicrobial resistance is essential for H. pylori management in clinical practice. METHODOLOGY: H. pylori isolates obtained from patients consecutively observed in a single center were tested for primary resistance by using E-test method. Bacterial strains showing MIC values >0.5,&thi...
CONCLUSION: FC-SEMS placement could be a safe and effective treatment in Type II perforations and represent a valuable development and innovation of conservative treatment. PMID: 29688094 [PubMed - as supplied by publisher]